Abstract

The factors which predispose a patient to neurosyphilis have been much discussed, but they are still obscure. In general three factors may be said to determine involvement of the central nervous system: variations in reaction of infected persons to<i>Spirochaeta pallida</i>, the strain of the infecting organism, and the amount and character of antisyphilitic treatment. Antisyphilitic treatment, properly employed, may prevent or suppress the development of clinical neurosyphilis; on the other hand, such treatment may, under certain conditions, favor its development or hasten its clinical onset. The occurrence of precocious clinical neurosyphilis following one or several doses of arsphenamin soon sobered early enthusiasm in the drug. It is unnecessary to dwell on the controversy concerning the origin of these so-called neurorecurrences or neurorecidives; they are now considered syphilitic in nature. From the opening of the Syphilis Clinic of the Johns Hopkins Hospital in 1914 to Sept. 1, 1921, 7,065 patients

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.